Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
Gross Profit
Jazz Pharmaceuticals PLC
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Gross Profit
$3.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Perrigo Company PLC
NYSE:PRGO
|
Gross Profit
$1.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Gross Profit
$52.8m
|
CAGR 3-Years
98%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
32%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Gross Profit
€57.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Ovoca Bio PLC
LSE:OVB
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jazz Pharmaceuticals PLC's Gross Profit?
Gross Profit
3.4B
USD
Based on the financial report for Mar 31, 2024, Jazz Pharmaceuticals PLC's Gross Profit amounts to 3.4B USD.
What is Jazz Pharmaceuticals PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
15%
Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for Jazz Pharmaceuticals PLC have been 15% over the past three years , 13% over the past five years , and 15% over the past ten years .